NCT06307457 A Study of HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark. Status COMPLETED Phase N/A
NCT06307249 Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA Status RECRUITING Phase PHASE1
NCT06305312 Community Services Navigation to Advance Health Equity in Breast Cancer Screening Status RECRUITING Phase NA
NCT06304857 CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIAL Status RECRUITING Phase PHASE3
NCT06300411 SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery Status COMPLETED Phase PHASE1
NCT06300099 Dexamethasone Versus Dexmedetomidine as Adjuncts to Serratus Anterior Plane Block Status NOT_YET_RECRUITING Phase PHASE4
NCT06299930 Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy Status COMPLETED Phase N/A
NCT06299202 Contrast-enhanced Spectral Mammography (CESM) Early Quantitative Evaluation of Tumoral Response and Pathologic Complete Response Prediction for Localized Breast Cancer Treated by Neoadjuvant Chemotherapy Status RECRUITING Phase NA
NCT06299124 A Phase I Study of RGT-419B in Patients With HR-Positive, HER2-Negative Advanced Breast Cancer or Other Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06297811 Myeloprotection With Trilaciclib in Pan-cancer Population Status NOT_YET_RECRUITING Phase PHASE2
NCT06293898 Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors Status RECRUITING Phase PHASE1
NCT06291324 WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment Status RECRUITING Phase N/A
NCT06288620 Microwave Ablation in the Treatment of Early-stage Unifocal Invasive Breast Cancer Status RECRUITING Phase NA
NCT06282796 Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy Status RECRUITING Phase N/A
NCT06281210 Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery Status RECRUITING Phase NA
NCT06281145 Stress-Reducing Intervention in Patients With Colorectal and Breast Cancer Status RECRUITING Phase NA
NCT06276868 Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer Status RECRUITING Phase PHASE2